Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)

SHA:600867 Revenue

Tonghua Dongbao Pharmaceutical had revenue of 915.98M CNY in the quarter ending September 30, 2026, with 13.63% growth. This brings the company's total for the last twelve months to 3.21B, up 16.17% year-over-year. In the year 2025, Tonghua Dongbao Pharmaceutical had annual revenue of 2.95B with 46.66% growth. That makes Tonghua Dongbao Pharmaceutical the 11,500th largest company in the world by revenue and 1,937th in China.

• Revenue (ttm): 3.21B
• Revenue Growth: +16.17%
• P/S Ratio: 4.85
• Revenue / Employee: 957.84K
• Employees: 3,354
• Market Cap: 15.57B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Industry 2.90B 99.7%
• Real Estate Industry 7.34M 0.3%

By Geography

Chart

• China 2.71B 93.0%
• Foreign 203.28M 7.0%

Fiscal year ended Dec 31, 2025 See the full SHA:600867 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.95B	937.63M	46.66%
Dec 31, 2024	2.01B	-1.07B	-34.66%
Dec 31, 2023	3.08B	296.96M	10.69%
Dec 31, 2022	2.78B	-489.44M	-14.98%
Dec 31, 2021	3.27B	375.73M	12.99%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error